Effect of Bupropion on Smoking Behavior in Smokers With Schizophrenia

Clinical trial NCT00218231 · COMPLETED

Trial details

NCT number: NCT00218231
Sponsor: National Institute on Drug Abuse (NIDA)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Schizophrenia Tobacco Use Disorder

Start date: 2004-01-01
Primary completion: 2006-08-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.